Renoprotective Effect of ALiskiren in Japanese Hypertensive Patients
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000005441
- Lead Sponsor
- Kanazawa Municipal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who have secondary hypertension (2) Patients with serum Cr =>2.0 mg/dL (3) Patients who have previous history of allergy to Aliskiren (4) Patients who are pregnant or have possibility of pregnancy and are lactation period (5) Patients who have ciclosporin or itraconazole (6) Patients who have bilateral or unilateral renal artery stenosis (7) Patients who have hyperkalemia (8) Patients who have nephrotic syndrome (9) Patients who were deemed not appropriate to participate in this study by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Change in blood pressure (2) Change in albuminuria
- Secondary Outcome Measures
Name Time Method Change before and after treatment of the following items: (1) PRA, PAC, serum creatinine, potassium (2) Change in eGFR